Cargando…

Radiation safety considerations for the use of radium-224-calciumcarbonate-microparticles in patients with peritoneal metastasis

AIM: Two ongoing phase I studies are investigating the use of radium-224 adsorbed to calcium carbonate micro particles ((224)Ra-CaCO(3)-MP) to treat peritoneal metastasis originating from colorectal or ovarian cancer. The aim of this work was to study the level of radiation exposure from the patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grønningsæter, Simen Rykkje, Blakkisrud, Johan, Selboe, Silje, Revheim, Mona-Elisabeth, Bruland, Øyvind Sverre, Bønsdorff, Tina Bjørnlund, Larsen, Stein Gunnar, Stokke, Caroline
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9945525/ https://www.ncbi.nlm.nih.gov/pubmed/36844217 http://dx.doi.org/10.3389/fmed.2023.1058914

Ejemplares similares

First experience with (224)Radium-labeled microparticles (Radspherin®) after CRS-HIPEC for peritoneal metastasis in colorectal cancer (a phase 1 study)
por: Larsen, Stein Gunnar, et al.
Publicado: (2023)

Effect of Intraperitoneal (224)Radium-Labelled Microparticles on Compartmentalized Inflammation After Cytoreductive Surgery and Hypertherm Intraperitoneal Chemotherapy
por: Thorgersen, Ebbe Billmann, et al.
Publicado: (2023)

Therapeutic Effect of α-Emitting (224)Ra-Labeled Calcium Carbonate Microparticles in Mice with Intraperitoneal Ovarian Cancer()()
por: Westrøm, Sara, et al.
Publicado: (2018)

Radon-220 diffusion from (224)Ra-labeled calcium carbonate microparticles: Some implications for radiotherapeutic use
por: Napoli, Elisa, et al.
Publicado: (2021)

Ra‐224 labeling of calcium carbonate microparticles for internal α‐therapy: Preparation, stability, and biodistribution in mice
por: Westrøm, Sara, et al.
Publicado: (2018)

Improved Formulation of (224)Ra-Labeled Calcium Carbonate Microparticles by Surface Layer Encapsulation and Addition of EDTMP
por: Li, Ruth Gong, et al.
Publicado: (2021)

Dual targeting with (224)Ra/(212)Pb-conjugates for targeted alpha therapy of disseminated cancers: A conceptual approach
por: Juzeniene, Asta, et al.
Publicado: (2023)

Targeted alpha therapy with the (224)Ra/(212)Pb-TCMC-TP-3 dual alpha solution in a multicellular tumor spheroid model of osteosarcoma
por: Tornes, Anna Julie Kjøl, et al.
Publicado: (2022)

A Novel Single-Step-Labeled (212)Pb-CaCO(3) Microparticle for Internal Alpha Therapy: Preparation, Stability, and Preclinical Data from Mice
por: Li, Ruth Gong, et al.
Publicado: (2021)

Intraperitoneal alpha therapy with (224)Ra-labeled microparticles combined with chemotherapy in an ovarian cancer mouse model
por: Wouters, Roxanne, et al.
Publicado: (2022)

FDG PET/CT and Dosimetric Studies of (177)Lu-Lilotomab Satetraxetan in a First-in-Human Trial for Relapsed Indolent non-Hodgkin Lymphoma—Are We Hitting the Target?
por: Løndalen, Ayca, et al.
Publicado: (2022)

In situ Generated (212)Pb-PSMA Ligand in a (224)Ra-Solution for Dual Targeting of Prostate Cancer Sclerotic Stroma and PSMA-Positive Cells
por: Stenberg, Vilde Y., et al.
Publicado: (2020)

FDG PET/CT parameters and correlations with tumor-absorbed doses in a phase 1 trial of (177)Lu-lilotomab satetraxetan for treatment of relapsed non-Hodgkin lymphoma
por: Løndalen, Ayca, et al.
Publicado: (2020)

Administration of lower doses of radium-224 to ankylosing spondylitis patients results in no evidence of significant overall detriment
por: Priest, Nicholas D., et al.
Publicado: (2020)

Monitoring the Effect of Targeted Therapies in a Gastrointestinal Stromal Tumor Xenograft Using a Clinical PET/CT
por: Revheim, Mona-Elisabeth, et al.
Publicado: (2010)

Factors Influencing the Therapeutic Efficacy of the PSMA Targeting Radioligand (212)Pb-NG001
por: Stenberg, Vilde Yuli, et al.
Publicado: (2022)

Multimodal functional imaging for early response assessment in GIST patients treated with imatinib
por: Revheim, Mona-Elisabeth, et al.
Publicado: (2014)

Radionuclides for Targeted Therapy: Physical Properties
por: Stokke, Caroline, et al.
Publicado: (2022)

Intermittent and continuous imatinib in a human GIST xenograft model carrying KIT exon 17 resistance mutation D816H
por: Revheim, Mona-Elisabeth, et al.
Publicado: (2013)

Preclinical and Clinical Status of PSMA-Targeted Alpha Therapy for Metastatic Castration-Resistant Prostate Cancer
por: Juzeniene, Asta, et al.
Publicado: (2021)

Editorial: Targeted alpha particle therapy in oncology
por: Bruland, Øyvind Sverre, et al.
Publicado: (2023)

Malignant Phyllodes Tumor and Acute Megakaryoblastic Leukemia Sharing a Common Clonal Origin
por: Fløisand, Yngvar, et al.
Publicado: (2013)

Evaluation of CD146 as Target for Radioimmunotherapy against Osteosarcoma
por: Westrøm, Sara, et al.
Publicado: (2016)

Optimized SPECT Imaging of (224)Ra α-Particle Therapy by (212)Pb Photon Emissions
por: Mikalsen, Lars Tore Gyland, et al.
Publicado: (2023)

Radium
Publicado: (1911)

Radium
Publicado: (1914)

Radium
por: Turner, Dawson
Publicado: (1904)

Radium
por: Hodgson, F. G.
Publicado: (1906)

Correlations between [(68)Ga]Ga-DOTA-TOC Uptake and Absorbed Dose from [(177)Lu]Lu-DOTA-TATE
por: Bruvoll, Ragnar, et al.
Publicado: (2023)

Radium Therapy
por: Shorten, J. A.
Publicado: (1922)

Radium and Cancer
Publicado: (1932)

Radium in Gynæcology
Publicado: (1928)

Radium and Vision
Publicado: (1904)

Radium Therapeutics
Publicado: (1914)

Radium in India
por: Connor, Frank Powell
Publicado: (1930)

Radium in Dermatology
por: Tomkinson, J. Goodwin
Publicado: (1909)

Radiocarcinoma and Radium
Publicado: (1933)

The Price of Radium
por: Watson and Sons (Electro-Medical), Ltd.,
Publicado: (1923)

The Radium Fetich
Publicado: (1916)

Radium and Cancer
por: Bibb, R. H. L.
Publicado: (1914)

Cannot write session to /tmp/vufind_sessions/sess_1vfhd4usbrqp9k6fkbi2cfbmc8